Literature DB >> 4401306

Resistance of noradrenaline in blood vessels to depletion by 6-hydroxydopamine or immunosympathectomy.

B A Berkowitz, S Spector, J H Tarver.   

Abstract

1. The degree of the decrease in the noradrenaline concentrations caused by 6-hydroxydopamine or immunosympathectomy was different in different areas of the cardiovascular system.2. In rats or guinea-pigs 6-hydroxydopamine depleted the noradrenaline content of the heart by 90%, of the mesenteric vein by 80% and of the mesenteric artery and aorta by 30-60%. Immunosympathectomy elicited a 70% reduction in the cardiac noradrenaline but only a 50% reduction in the noradrenaline of the blood vessels of the rat.3. The tyrosine hydroxylase activity of the heart, blood vessels, or adrenal glands was not significantly altered 2 weeks after 6-hydroxydopamine. Nor was the monoamine oxidase activity in heart or blood vessels changed.4. The inconsistent ability of both 6-hydroxydopamine and immunosympathectomy to abolish experimental hypertension may be due to the partial persistence of noradrenaline and functional sympathetic nervous system activity in the blood vessels.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401306      PMCID: PMC1665696          DOI: 10.1111/j.1476-5381.1972.tb07233.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

1.  A comparison of the effects of 6-hydroxydopamine immunosympathectomy and reserpine on the cardiovascular reactivity in the rat.

Authors:  L Finch; G D Leach
Journal:  J Pharm Pharmacol       Date:  1970-05       Impact factor: 3.765

2.  Antihypertensive effect of methyldopa in metacorticoid immunosympathectomized rats.

Authors:  D R Varma
Journal:  J Pharm Pharmacol       Date:  1967-01       Impact factor: 3.765

3.  Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.

Authors:  H Thoenen; J P Tranzer
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Increased tyrosine hydroxylase activity after drug-induced alteration of sympathetic transmission.

Authors:  H Thoenen; R A Mueller; J Axelrod
Journal:  Nature       Date:  1969-03-29       Impact factor: 49.962

5.  Trans-synaptic induction of adrenal tyrosine hydroxylase.

Authors:  H Thoenen; R A Mueller; J Axelrod
Journal:  J Pharmacol Exp Ther       Date:  1969-10       Impact factor: 4.030

6.  Increased synthesis of catecholamines and their metabolites following the administration of phenoxybenzamine.

Authors:  L B Bigelow; W Dairman; H Weil-Malherbe; S Udenfriend
Journal:  Mol Pharmacol       Date:  1969-11       Impact factor: 4.436

7.  Second symposium on catecholamines. Modification of sympathetic function. Immunosympathectomy.

Authors:  R Levi-Montalcini; P U Angeletti
Journal:  Pharmacol Rev       Date:  1966-03       Impact factor: 25.468

8.  The influence of sympathetic innervation on vascular sensitivity to noradrenaline.

Authors:  I S De la Lande; D Frewin; J G Waterson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

9.  The synthesis of 2,4,5-trihydroxyphenylalanine (6-hydroxydopa). A centrally active norepinephrine-depleting agent.

Authors:  H H Ong; C R Creveling; J W Daly
Journal:  J Med Chem       Date:  1969-05       Impact factor: 7.446

10.  Catecholamine and 5-hydroxyindole metabolism in immunosympathectomized rats.

Authors:  P M Ceasar; C R Ruthven; M Sandler
Journal:  Br J Pharmacol       Date:  1969-05       Impact factor: 8.739

View more
  14 in total

1.  Cardiovascular effects of the novel histamine H2 receptor agonist amthamine: interaction with the adrenergic system.

Authors:  G Coruzzi; E Gambarelli; G Bertaccini; H Timmerman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-03       Impact factor: 3.000

2.  Regeneration of the noradrenergic innervation of the cardiovascular system of the chick following treatment with 6-hydroxydopamine.

Authors:  T Bennett; T Malmfors
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

3.  Effects of 6-hydroxydopamine on spontaneously hypertensive rats.

Authors:  H Vapaatalo; R Hackman; P Anttila; V Vainionpää; P J Neuvonen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

4.  On the cardiovascular action of dopamine in rats.

Authors:  P J Neuvonen; E Westermann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

5.  Monoamine oxidase in rat arteries: evidence for different forms and selective localization.

Authors:  J F Coquil; C Goridis; G Mack; N H Neff
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

Review 6.  6-hydroxydopamine destruction of central adrenergic neurones prevents or reverses developing DOCA-salt hypertension in rats.

Authors:  F Lamprecht; J S Richardson; R B Williams; I J Kopin
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

7.  Rapid recovery of vascular adrenergic nerves in the rat after chemical sympathectomy with 6-hydroxydopamine.

Authors:  L Finch; G Haeusler; H Kuhn; H Thoenen
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

8.  The effects of an anti-atherosclerotic drug, pyridinolcarbamate, on heart, vascular and brain biogenic amines.

Authors:  B A Berkowitz; H Hidaka; S Spector
Journal:  Br J Pharmacol       Date:  1973-05       Impact factor: 8.739

9.  Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.

Authors:  L Finch; G Haeusler
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

10.  Control of pineal indole biosynthesis by changes in sympathetic tone caused by factors other than environmental lighting.

Authors:  H J Lynch; J P Eng; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.